c-Jun N-terminal kinase in synergistic neurite outgrowth in PC12 cells mediated through P90RSK

BMC Neuroscience

Heng-Phon Too¹  Gregory Stephanopoulos²  Lihan Zhou¹  Kok Huei Seow³ 

[1] Department of Biochemistry, National University of Singapore, 14 Medical Drive, Singapore, Singapore;Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, USA;Chemical & Pharmaceutical Engineering, Singapore-MIT Alliance, 4 Engineering Drive 3, Singapore, Singapore

关键词: P90RSK;    JNK;    Neurite outgrowth;    PACAP;    EGF;    FGFb;    NGF;    Synergistic;    PC12;   

Others  :  1122704
DOI  :  10.1186/1471-2202-14-153

 received in 2013-04-23, accepted in 2013-12-05,  发布年份 2013

【 摘 要 】

Background

Synergistic multi-ligand treatments that can induce neuronal differentiation offer valuable strategies to regulate and modulate neurite outgrowth. Whereas the signaling pathways mediating single ligand-induced neurite outgrowth, such as Akt, extracellular signal-regulated kinase (Erk), c-Jun N-terminal kinase (JNK), and p38 mitogen-activated protein kinase (P38), have been extensively studied, the mechanisms underlying multi-ligand synergistic neurite outgrowth are poorly understood. In an attempt to gain insight into synergistic neurite outgrowth, PC12 cells were treated with one of three combinations: pituitary adenylate cyclase-activating peptide (PACAP) with epidermal growth factor (EP), basic fibroblast growth factor (FP), or nerve growth factor (NP) and then challenged with the appropriate kinase inhibitors to assess the signaling pathways involved in the process.

Results

Response surface analyses indicated that synergistic neurite outgrowth was regulated by distinct pathways in these systems. Synergistic increases in the phosphorylation of Erk and JNK, but not Akt or P38, were observed with the three growth factor-PACAP combinations. Unexpectedly, we identified a synergistic increase in JNK phosphorylation, which was involved in neurite outgrowth in the NP and FP, but not EP, systems. Inhibition of JNK using the SP600125 inhibitor reduced phosphorylation of 90 kDa ribosomal S6 kinase (P90RSK) in the NP and FP, but not EP, systems. This suggested the involvement of P90RSK in mediating the differential effects of JNK in synergistic neurite outgrowth.

Conclusions

Taken together, these findings reveal the involvement of distinct signaling pathways in regulating neurite outgrowth in response to different synergistic growth factor-PACAP treatments. Our findings demonstrate a hitherto unrecognized mechanism of JNK-P90RSK in mediating synergistic neurite outgrowth induced by the co-treatment of growth factors and PACAP.

【 授权许可】

   
2013 Seow et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

【 参考文献 】

• [1]Zimmermann GR, Lehar J, Keith CT: Multi-target therapeutics: when the whole is greater than the sum of the parts. Drug Discov Today 2007, 12:34-42.
• [2]Chou TC: Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 2010, 70:440-446.
• [3]Jia J, Zhu F, Ma X, Cao Z, Li Y, Chen YZ: Mechanisms of drug combinations: interaction and network perspectives. Nat Rev Drug Discov 2009, 8:111-128.
• [4]Lehar J, Krueger AS, Avery W, Heilbut AM, Johansen LM, Price ER, Rickles RJ, Short GF 3rd, Staunton JE, Jin X, et al.: Synergistic drug combinations tend to improve therapeutically relevant selectivity. Nat Biotechnol 2009, 27:659-666.
• [5]Kamb A, Wee S, Lengauer C: Why is cancer drug discovery so difficult? Nat Rev Drug Discov 2007, 6:115-120.
• [6]Logan A, Ahmed Z, Baird A, Gonzalez AM, Berry M: Neurotrophic factor synergy is required for neuronal survival and disinhibited axon regeneration after CNS injury. Brain 2006, 129:490-502.
• [7]Madduri S, Papaloizos M, Gander B: Synergistic effect of GDNF and NGF on axonal branching and elongation in vitro. Neurosci Res 2009, 65:88-97.
• [8]Jones DM, Tucker BA, Rahimtula M, Mearow KM: The synergistic effects of NGF and IGF-1 on neurite growth in adult sensory neurons: convergence on the PI 3-kinase signaling pathway. J Neurochem 2003, 86:1116-1128.
• [9]Soumyanath A, Zhong YP, Gold SA, Yu X, Koop DR, Bourdette D, Gold BG: Centella asiatica accelerates nerve regeneration upon oral administration and contains multiple active fractions increasing neurite elongation in-vitro. J Pharm Pharmacol 2005, 57:1221-1229.
• [10]Gordon T: The role of neurotrophic factors in nerve regeneration. Neurosurg Focus 2009, 26:E3.
• [11]Greene LA, Tischler AS: Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A 1976, 73:2424-2428.
• [12]Rydel RE, Greene LA: Acidic and basic fibroblast growth factors promote stable neurite outgrowth and neuronal differentiation in cultures of PC12 cells. J Neurosci 1987, 7:3639-3653.
• [13]Vaudry D, Stork PJ, Lazarovici P, Eiden LE: Signaling pathways for PC12 cell differentiation: making the right connections. Science 2002, 296:1648-1649.
• [14]Kao S, Jaiswal RK, Kolch W, Landreth GE: Identification of the mechanisms regulating the differential activation of the mapk cascade by epidermal growth factor and nerve growth factor in PC12 cells. J Biol Chem 2001, 276:18169-18177.
• [15]Waetzig V, Herdegen T: The concerted signaling of ERK1/2 and JNKs is essential for PC12 cell neuritogenesis and converges at the level of target proteins. Mol Cell Neurosci 2003, 24:238-249.
• [16]Yung LY, Tso PH, Wu EHT, Yu JCH, Ip NY, Wong YH: Nerve growth factor-induced stimulation of p38 mitogen-activated protein kinase in PC12 cells is partially mediated via Gi/o proteins. Cell Signal 2008, 20:1538-1544.
• [17]Tso PH, Morris CJ, Yung LY, Ip NY, Wong YH: Multiple Gi proteins participate in nerve growth factor-induced activation of c-Jun N-terminal kinases in PC12 cells. Neurochem Res 2009, 34:1101-1112.
• [18]Kim Y, Seger R, Suresh Babu CV, Hwang SY, Yoo YS: A positive role of the PI3-K/Akt signaling pathway in PC12 cell differentiation. Mol Cells 2004, 18:353-359.
• [19]Wu CF, Howard BD: K252a-potentiation of EGF-induced neurite outgrowth from PC12 cells is not mimicked or blocked by other protein kinase activators or inhibitors. Brain Res Dev Brain Res 1995, 86:217-226.
• [20]Erhardt JA, Pittman RN: Ectopic p21(WAF1) expression induces differentiation-specific cell cycle changes in PC12 cells characteristic of nerve growth factor treatment. J Biol Chem 1998, 273:23517-23523.
• [21]Traverse S, Gomez N, Paterson H, Marshall C, Cohen P: Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem J 1992, 288(Pt 2):351-355.
• [22]Mark MD, Storm DR: Coupling of epidermal growth factor (EGF) with the antiproliferative activity of cAMP induces neuronal differentiation. J Biol Chem 1997, 272:17238-17244.
• [23]Yao H, Labudda K, Rim C, Capodieci P, Loda M, Stork PJ: Cyclic adenosine monophosphate can convert epidermal growth factor into a differentiating factor in neuronal cells. J Biol Chem 1995, 270:20748-20753.
• [24]Wolff P, Abreu PA, Espreafico EM, Costa MC, Larson RE, Ho PL: Characterization of myosin V from PC12 cells. Biochem Biophys Res Commun 1999, 262:98-102.
• [25]Sakai Y, Hashimoto H, Shintani N, Tomimoto S, Tanaka K, Ichibori A, Hirose M, Baba A: Involvement of p38 MAP kinase pathway in the synergistic activation of PACAP mRNA expression by NGF and PACAP in PC12h cells. Biochem Biophys Res Commun 2001, 285:656-661.
• [26]Hansen TO, Rehfeld JF, Nielsen FC: Cyclic AMP-induced neuronal differentiation via activation of p38 mitogen-activated protein kinase. J Neurochem 2000, 75:1870-1877.
• [27]Sakai Y, Hashimoto H, Shintani N, Katoh H, Negishi M, Kawaguchi C, Kasai A, Baba A: PACAP activates Rac1 and synergizes with NGF to activate ERK1/2, thereby inducing neurite outgrowth in PC12 cells. Brain Res Mol Brain Res 2004, 123:18-26.
• [28]Wang D, Lagerstrom R, Sun C, Bishof L, Valotton P, Gotte M: HCA-Vision: automated Neurite Outgrowth Analysis. J Biomol Screen 2010, 15:1165-1170.
• [29]Barrera NP, Morales B, Torres S, Villalon M: Principles: mechanisms and modeling of synergism in cellular responses. Trends Pharmacol Sci 2005, 26:526-532.
• [30]Chou TC: Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 2006, 58:621-681.
• [31]Marshall CJ: Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995, 80:179-185.
• [32]Nakajima T, Fukamizu A, Takahashi J, Gage FH, Fisher T, Blenis J, Montminy MR: The signal-dependent coactivator CBP is a nuclear target for pp90RSK. Cell 1996, 86:465-474.
• [33]Silverman E, Frodin M, Gammeltoft S, Maller JL: Activation of p90 Rsk1 is sufficient for differentiation of PC12 cells. Mol Cell Biol 2004, 24:10573-10583.
• [34]Zhang Y, Zhong S, Dong Z, Chen N, Bode AM, Ma W: UVA induces Ser381 phosphorylation of p90RSK/MAPKAP-K1 via ERK and JNK pathways. J Biol Chem 2001, 276:14572-14580.
• [35]Fomina-Yadlin D, Kubicek S, Walpita D, Dancik V, Hecksher-Sorensen J, Bittker JA, Sharifnia T, Shamji A, Clemons PA, Wagner BK, Schreiber SL: Small-molecule inducers of insulin expression in pancreatic alpha-cells. Proc Natl Acad Sci U S A 2010, 107:15099-15104.
• [36]Park YS, Cho NJ: EGFR and PKC are involved in the activation of ERK1/2 and p90 RSK and the subsequent proliferation of SNU-407 colon cancer cells by muscarinic acetylcholine receptors. Mol Cell Biochem 2012, 370:191-198.
• [37]Anjum R, Blenis J: The RSK family of kinases: emerging roles in cellular signalling. Nat Rev Mol Cell Biol 2008, 9:747-758.
• [38]Romeo Y, Zhang X, Roux PP: Regulation and function of the RSK family of protein kinases. Biochem J 2012, 441:553-569.
• [39]Kamata Y, Shiraga H, Tai A, Kawamoto Y, Gohda E: Induction of neurite outgrowth in PC12 cells by the medium-chain fatty acid octanoic acid. Neuroscience 2007, 146:1073-1081.
• [40]Riese U, Ziegler E, Hamburger M: Militarinone A induces differentiation in PC12 cells via MAP and Akt kinase signal transduction pathways. FEBS Lett 2004, 577:455-459.
• [41]Xu H, Dhanasekaran DN, Lee CM, Reddy EP: Regulation of neurite outgrowth by interactions between the scaffolding protein, JNK-associated leucine zipper protein, and neuronal growth-associated protein superior cervical ganglia clone 10. J Biol Chem 2010, 285:3548-3553.
• [42]Chen X, Fu W, Tung CE, Ward NL: Angiopoietin-1 induces neurite outgrowth of PC12 cells in a Tie2-independent, beta1-integrin-dependent manner. Neurosci Res 2009, 64:348-354.
• [43]Klesse LJ, Meyers KA, Marshall CJ, Parada LF: Nerve growth factor induces survival and differentiation through two distinct signaling cascades in PC12 cells. Oncogene 1999, 18:2055-2068.
• [44]Yan C, Liang Y, Nylander KD, Schor NF: TrkA as a life and death receptor: receptor dose as a mediator of function. Cancer Res 2002, 62:4867-4875.
• [45]Read DE, Reed Herbert K, Gorman AM: Heat shock enhances NGF-induced neurite elongation which is not mediated by Hsp25 in PC12 cells. Brain Res 2008, 1221:14-23.
• [46]Chen JY, Lin JR, Cimprich KA, Meyer T: A two-dimensional ERK-AKT signaling code for an NGF-triggered cell-fate decision. Mol Cell 2012, 45:196-209.
• [47]Heasley LE, Storey B, Fanger GR, Butterfield L, Zamarripa J, Blumberg D, Maue RA: GTPase-deficient G alpha 16 and G alpha q induce PC12 cell differentiation and persistent activation of cJun NH2-terminal kinases. Mol Cell Biol 1996, 16:648-656.
• [48]Waetzig V, Herdegen T: MEKK1 controls neurite regrowth after experimental injury by balancing ERK1/2 and JNK2 signaling. Mol Cell Neurosci 2005, 30:67-78.
• [49]Christensen AE, Selheim F, de Rooij J, Dremier S, Schwede F, Dao KK, Martinez A, Maenhaut C, Bos JL, Genieser HG, Doskeland SO: cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension. J Biol Chem 2003, 278:35394-35402.
• [50]Kopperud R, Krakstad C, Selheim F, Doskeland SO: cAMP effector mechanisms. Novel twists for an ‘old’ signaling system. FEBS Lett 2003, 546:121-126.
• [51]Gerits N, Kostenko S, Shiryaev A, Johannessen M, Moens U: Relations between the mitogen-activated protein kinase and the cAMP-dependent protein kinase pathways: comradeship and hostility. Cell Signal 2008, 20:1592-1607.
• [52]Moxham CM, Tabrizchi A, Davis RJ, Malbon CC: Jun N-terminal kinase mediates activation of skeletal muscle glycogen synthase by insulin in vivo. J Biol Chem 1996, 271:30765-30773.
• [53]Samaga R, Saez-Rodriguez J, Alexopoulos LG, Sorger PK, Klamt S: The logic of EGFR/ErbB signaling: theoretical properties and analysis of high-throughput data. PLoS Comput Biol 2009, 5:e1000438.
• [54]Leppa S, Saffrich R, Ansorge W, Bohmann D: Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation. EMBO J 1998, 17:4404-4413.
• [55]Eriksson M, Taskinen M, Leppa S: Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells. J Cell Physiol 2007, 210:538-548.
• [56]Marek L, Levresse V, Amura C, Zentrich E, Van Putten V, Nemenoff RA, Heasley LE: Multiple signaling conduits regulate global differentiation-specific gene expression in PC12 cells. J Cell Physiol 2004, 201:459-469.
• [57]Zentrich E, Han SY, Pessoa-Brandao L, Butterfield L, Heasley LE: Collaboration of JNKs and ERKs in nerve growth factor regulation of the neurofilament light chain promoter in PC12 cells. J Biol Chem 2002, 277:4110-4118.
• [58]Smith JA, Poteet-Smith CE, Malarkey K, Sturgill TW: Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo. J Biol Chem 1999, 274:2893-2898.